Skip to content

The evaluation of the effect of cocoa on periodontal disaese

The evaluation of the effect of cocoa on total antioxidant capacity and lipid oxidation in saliva on moderate chronic periodontitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201309303813N3
Enrollment
40
Registered
2014-05-29
Start date
2013-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate Chronic Periodontitis. Chronic Periodontitis

Interventions

Intervention 1: The intervention group intake daily 30 gram Idin78% dark chocolate in three dosage for four weeks. Intervention 2: The control group intake daily 23.4 gram Idin white chocolate in th
The intervention group intake daily 30 gram Idin78% dark chocolate in three dosage for four weeks.
The control group intake daily 23.4 gram Idin white chocolate in three dosage for four weeks.

Sponsors

Babol University of Medical Sience, Vice Chancellor for Research and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:The patients without history of systemic disease ; The patients without sensitivity to coca and it's products;The patients age between 30 to 50 ; The patients have chronic moderate periodontitis ;The patients be able to cooperate and have same plaque index; The patients without digestive problem Exclusion criteria: smoker patients; menopause women;the patients who intake nutritional and vitamin supplements; the patients who cocoa and it's products are in they daily nutritional regiment; the patients whit any periodontal treatment during past 6 month; the patients whit antibiotic therapy during 1 month; the patients had taken anti inflammatory drugs during past 1 month.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Total Antioxidant Power. Timepoint: At base line and One month after intervention. Method of measurement: Ferric Reducing Antioxidant power test-FRAP.;Saliva lipid preoxidation. Timepoint: At base line and One month after intervention. Method of measurement: Thiobarbituric Acid Reactive Substances test-TBARS.

Secondary

MeasureTime frame
Gingival Index. Timepoint: this index will be recorded at base line and 2 , 4 ,6 and 8 weeks later. Method of measurement: loe and silness method.;Modified papillary bleeding index. Timepoint: this index will be recorded at base line and 2 , 4 ,6 and 8 weeks later. Method of measurement: Bernet method.;Probind pocket depth. Timepoint: this index will be recorded at base line and 2 , 4 ,6 and 8 weeks later. Method of measurement: whit periodontal probe.;Attachment loss. Timepoint: this index will be recorded at base line and 2 , 4 ,6 and 8 weeks later. Method of measurement: whit periodontal probe.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiloofar Jenabian

Babol University of Medical Sience

njenabian@hotmail.com njenabian@yahoo.com+98 11 1222 4032

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026